← All trials
NCT07111520
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 22, 2025
- Primary completion
- Jan 31, 2029
- Completion date
- Jan 31, 2030
- First posted
- Aug 8, 2025
- Last posted
- Oct 22, 2025
- Enrollment
- 420
- Arms / groups
- 15 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BiontechLead sponsor
- Suzhou Medilink Therapeutics Ltd.Collaborator
- BiontechOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.